Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000904454-14-000137
Filing Date
2014-02-04
Accepted
2014-02-04 18:43:42
Documents
1
Period of Report
2014-02-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 6083
  Complete submission text file 0000904454-14-000137.txt   8051
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Reporting) CIK: 0000200406 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 1212
Type: 3 | Act: 34 | File No.: 001-36289 | Film No.: 14573865
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
JOHNSON & JOHNSON DEVELOPMENT CORP ET AL (Reporting) CIK: 0000924020 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36289 | Film No.: 14573864

Mailing Address 161 FIRST STREET SUITE 2C CAMBRIDGE MA 02139
Business Address 161 FIRST STREET SUITE 2C CAMBRIDGE MA 02139 617-876-8191
GENOCEA BIOSCIENCES, INC. (Issuer) CIK: 0001457612 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2836 Biological Products, (No Diagnostic Substances)